A Single and Multiple Dose Pharmacokinetic Study of Perampanel in Chinese Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 04 Jul 2018
At a glance
- Drugs Perampanel (Primary)
- Indications Epilepsy; Partial epilepsies; Seizures; Tonic-clonic epilepsy
- Focus Pharmacokinetics
- Sponsors Eisai Co Ltd
- 25 Jun 2018 Status changed from active, no longer recruiting to completed.
- 21 May 2018 Planned End Date changed from 1 Jun 2018 to 1 May 2018.
- 21 May 2018 Planned primary completion date changed from 1 Jun 2018 to 1 May 2018.